Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis
OPEN BMC psychiatry | 10 Feb 2017
JC Jakobsen, KK Katakam, A Schou, SG Hellmuth, SE Stallknecht, K Leth-Møller, M Iversen, MB Banke, IJ Petersen, SL Klingenberg, J Krogh, SE Ebert, A Timm, J Lindschou and C Gluud
Abstract
The evidence on selective serotonin reuptake inhibitors (SSRIs) for major depressive disorder is unclear.
- Tweets*
- 650
- Facebook likes*
- 42
- Reddit*
- 5
- News coverage*
- 28
- Blogs*
- 9
- SC clicks
- 0
- Concepts
- Reuptake inhibitor, Paroxetine, Fluoxetine, Sertraline, Major depressive disorder, Serotonin, Selective serotonin reuptake inhibitor
- MeSH headings
- -
comments powered by Disqus
* Data courtesy of Altmetric.com